BRCA2
Tumor suppressor gene; mutations confer sensitivity to PARP inhibitors and platinum-based chemotherapy.
No Treatments found for this biomarker.
Tumor suppressor gene; mutations confer sensitivity to PARP inhibitors and platinum-based chemotherapy.
No Treatments found for this biomarker.